FDA approves expanded use of Gardasil 9 to include women and men 27 through 45 years old

What’s new? The U.S. Food and Drug Administration today approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine from males and females aged 9 through 26 years to include men and women aged 27 through 45 years. Gardasil 9 prevents certain cancers and diseases caused by the nine HPV […]